Inventor · disambiguated record
Martha Alicia De La Rosa
Also filed as: DE LA ROSA MARTHA · DE LA ROSA MARTHA A · DE LA ROSA MARTHA ALICIA
24 granted patents·14 pending applications·202 citations·filing 2003–2023
95Inventor score
Files withGLAXOSMITHKLINE IP DEV LTD11ARDEA BIOSCIENCES INC6GIRARDET JEAN-LUC6GLAXOSMITHKLINE IP NO 2 LTD5VERNIER JEAN-MICHEL3
Top patents by PatentIndex Score
38 records- 0198US7683087B2N[S(4-aryl-triazol-3-yl)α-mercaptoacetyl] -p-amino benzoic acids as HIV reverse transcriptase inhibitorsARDEA BIOSCIENCES INC·Filed 2008·Granted Mar 23, 2010·34 cites·36 claims
- 0298US7435752B2N[S(4-aryl-triazol-3-yl)α-mercaptoacetyl]-p-amino benozioc acids as HIV reverse transcriptase inhibitorsARDEA BIOSCIENCES INC·Filed 2005·Granted Oct 14, 2008·50 cites·19 claims
- 0395US8106205B2N[S(4-aryl-triazol-3-yl)α-mercaptoacetyl]p-amino benzoic acids as HIV reverse transcriptase inhibitorsGIRARDET JEAN-LUC·Filed 2010·Granted Jan 31, 2012·13 cites·1 claims
- 0491US7947721B2S-triazolyl α-mercaptoacetanilides as inhibitors of HIV reverse transcriptaseARDES BIOSCIENCES INC·Filed 2005·Granted May 24, 2011·26 cites·13 claims
- 0590US8552043B2N[S(4-aryl-triazol-3-yl)α-mercaptoacetyl]-p-amino benzoic acids as HIV reverse transcriptase inhibitorsGIRARDET JEAN-LUC·Filed 2011·Granted Oct 8, 2013·5 cites·9 claims
- 0688US10358427B2Modulators of indoleamine 2,3-dioxygenaseGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Granted Jul 23, 2019·11 cites·8 claims
- 0788US8993593B2N-(4-(6-fluoro-3,4-dihydroisoquinolin-2(1H)-yl)-2,6-dimethylphenyl)-3,3-dimethylbutanamide as potassium channel modulatorsVERNIER JEAN-MICHEL·Filed 2010·Granted Mar 31, 2015·18 cites·2 claims
- 0888US8293911B2Derivatives of 4-(n-azacycloalkyl) anilides as potassium channel modulatorsVERNIER JEAN-MICHEL·Filed 2007·Granted Oct 23, 2012·20 cites·13 claims
- 0988US8252828B2S-triazolyl α-mercapto acetanilides as inhibitors of HIV reverse transcriptaseGIRARDET JEAN-LUC·Filed 2011·Granted Aug 28, 2012·7 cites·6 claims
- 1082US8481581B2S-triazolyl α-mercaptoacetanilides as inhibitors of HIV reverse transcriptaseGIRARDET JEAN-LUC·Filed 2012·Granted Jul 9, 2013·3 cites·8 claims
- 1182US8372807B2Methods of modulating uric acid levelsARDEA BIOSCIENCES INC·Filed 2010·Granted Feb 12, 2013·8 cites·15 claims
- 1282US2024182473A1Compounds useful in hiv therapyGLAXOSMITHKLINE IP DEV LTD·Filed 2023·Application pending·0 cites
- 1380US8946273B2S-Triazolyl alpha-mercapto acetanilides as inhibitors of HIV reverse transcriptaseGIRARDET JEAN-LUC·Filed 2011·Granted Feb 3, 2015·3 cites·10 claims
- 1476US2024051972A1Compounds Useful in HIV TherapyGLAXOSMITHKLINE IP DEV LTD·Filed 2022·Application pending·0 cites
- 1570US8609653B2Azaindole compounds and methods for treating HIVDE LA ROSA MARTHA ALICIA·Filed 2012·Granted Dec 17, 2013·3 cites·11 claims
- 1669US2022411425A1Compounds useful in hiv therapyGLAXOSMITHKLINE IP DEV LTD·Filed 2021·Application pending·0 cites
- 1766US2008249131A1Non-nucleoside reverse transcriptase inhibitorsARDEA BIOSCIENCES INC·Filed 2008·Application pending·0 cites
- 1866US2015094284A1S-triazolyl alpha-mercapto acetanilides as inhibitors of hiv reverse transcriptaseARDEA BIOSCIENCES INC·Filed 2014·Application pending·0 cites
- 1964US9163023B2Compounds and methods for treating HIVVIIV HEALTHCARE UK LTD·Filed 2013·Granted Oct 20, 2015·1 cites·17 claims
- 2062US2018002296A1S-triazolyl alpha-mercapto acetanilides as inhibitors of hiv reverse transcriptaseARDEA BIOSCIENCES INC·Filed 2017·Application pending·0 cites
- 2157US10899754B2Modulators of indoleamine 2,3-dioxygenaseGLAXOSMITHKLINE IP DEV LTD·Filed 2017·Granted Jan 26, 2021·0 cites·5 claims
- 2251US10906924B2Modulators of indoleamine 2,3-dioxygenaseGLAXOSMITHKLINE IP DEV LTD·Filed 2018·Granted Feb 2, 2021·0 cites·17 claims
- 2350US8563566B2Naphthyridine derivatives as potassium channel modulatorsVERNIER JEAN-MICHEL·Filed 2008·Granted Oct 22, 2013·0 cites·43 claims
- 2450US8367684B2Derivatives of 4-(N-azacycloalkyl) anilides as potassium channel modulatorsVALEANT PHARMACEUTICALS INT·Filed 2008·Granted Feb 5, 2013·0 cites·43 claims
- 2550US2008045534A1Derivatives of 1,3-diamino benzene as potassium channel modulatorsVALEANT PHARMACEUTICALS NORTH·Filed 2007·Application pending·0 cites
- 2649US10787442B2Modulators of indoleamine 2,3-dioxygenaseGLAXOSMITHKLINE IP DEV LTD·Filed 2017·Granted Sep 29, 2020·0 cites·2 claims
- 2748US2022298160A1Compounds useful in hiv therapyGLAXOSMITHKLINE IP NO 2 LTD·Filed 2020·Application pending·0 cites
- 2848US2006135556A1Non-nucleoside reverse transcriptase inhibitorsGIRARDET JEAN-LUC·Filed 2003·Application pending·0 cites
- 2945US10239894B2Inhibitors of indoleamine 2,3-dioxygenaseGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Granted Mar 26, 2019·0 cites·7 claims
- 3044US10927078B2Modulators of indoleamine 2,3-dioxygenaseGLAXOSMITHKLINE IP DEV LTD·Filed 2018·Granted Feb 23, 2021·0 cites·16 claims
- 3143US10472336B2Modulators of indoleamine 2,3-dioxygenaseGLAXOSMITHKLINE IP NO 2 LTD·Filed 2016·Granted Nov 12, 2019·0 cites·11 claims
- 3243US2021323993A1Compounds Useful in HIV TherapyGLAXOSMITHKLINE IP NO 2 LTD·Filed 2019·Application pending·0 cites
- 3342US10538495B2Modulators of indoleamine 2,3-dioxygenaseGLAXOSMITHKLINE IP DEV LTD·Filed 2017·Granted Jan 21, 2020·0 cites·2 claims
- 3442US2021139467A1Modulators of indoleamine 2,3-dioxygenaseGLAXOSMITHKLINE IP DEV LTD·Filed 2018·Application pending·0 cites
- 3542US2020407393A1Medical UseGLAXOSMITHKLINE IP NO 2 LTD·Filed 2019·Application pending·0 cites
- 3642US2022117993A1Compounds Useful in HIV TherapyGLAXOSMITHKLINE IP NO 2 LTD·Filed 2019·Application pending·0 cites
- 3739US9029391B2Isoquinoline compounds and methods for treating HIVDE LA ROSA MARTHA ALICIA·Filed 2012·Granted May 12, 2015·0 cites·5 claims
- 3836US2012122780A1Compounds, Compositions and Methods for Modulating Uric Acid LevelsDE LA ROSA MARTHA·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →